Viewing nowCombinationEmpavex 5/1000 mg (empagliflozin, metformin hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.

MFDS item code 202501667 · Approved 2025.07.04 · Insurance code 652904720
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise in adult patients with type 2 diabetes to improve blood sugar control. It is particularly suitable for patients whose blood sugar levels are not sufficiently controlled, and may be used under medical supervision in cases where cardiovascular disease is present. This assists in managing the risk of cardiovascular events while improving blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see section 3. Patients Requiring Caution in Use, item 1) under Precautions for Use). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see section 2. Patients in Whom This Medicine Must Not Be Used, item 2) under Precautions for Use). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar levels. Rare side effects such as severe lactic acidosis may occur during treatment. Caution is needed when used with other diabetes medications, as hypoglycemia may occur. Patients with moderate to severe renal impairment, acute kidney problems, severe infections, or heart failure should not take this medication. It should be temporarily discontinued prior to examinations using iodinated contrast agents and resumed only after normal kidney function is confirmed. It is also advisable to discontinue use for a certain period prior to surgery and to resume post-recovery. Patients who consume alcohol excessively or have impaired liver function should avoid using this medication. Women who are pregnant or breastfeeding should not use this medication. Regular kidney function tests should be conducted while on this medication, and any symptoms of hypoglycemia or infection should be reported to a healthcare provider immediately. This medication may increase the risk of urinary and genital infections, so prompt treatment is necessary if infection symptoms arise. Vitamin B12 levels may decrease; thus, a B12 test is recommended for prolonged use. Gastrointestinal disturbances such as dizziness, vomiting, diarrhea, and abdominal pain may occur, and if symptoms are severe, consultation with a physician is necessary. Elderly patients are at higher risk of renal impairment and should take special care during use. Blood sugar control should be regularly monitored during treatment, and proper measures must be taken in case of hypoglycemic symptoms. In case of overdose, immediate hospital visit for appropriate treatment is required, especially if symptoms of lactic acidosis arise, which need emergency treatment. Keep the medication out of reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain a room temperature between 1 degree and 30 degrees Celsius for safe storage of the medication's effectiveness.
A yellow, brownish, double-convex, film-coated tablet.
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.